Changyu Liu

Prof. Dr. Changyu Liu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2025 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
MXMengdai Xu
Mengdai Xu
XCXi Chen
Xi Chen
SDShasha Du
Shasha Du
HXHuanhuan Xu
Huanhuan Xu
CLChangyu Liu
Changyu Liu
Objective: Osteoarthritis (OA) is the most prevalent chronic articular disease in adults. The degree of cartilage degradation and matrix depletion in OA have been substantially connected with chondrocyte inflammatory response. Consequently, pharmacological anti-inflammatory agents provide OA patients a new therapeutic option. Isoginkgetin (IGK), a bioactive bioflavonoid derived from the medicinal herb Ginkgo Biloba, defends against obesity-induced heart diastolic dysfunction and harmful remodeling. Whether IGK has a regulatory effect on OA remains unknown. This study investigated whether IGK could attenuate the progression of OA both in vivo and in vitro. Methods: Cell Counting Kit-8 (CCK8) was used to measure the vitality of chondrocytes. Mediators of inflammation, anabolism and catabolism were tested by Western blot and RT-PCR. Safranin-O staining, Hematoxylin–Eosin (H&E) staining, immunofluorescence, and Osteoarthritis Research Society International (OARSI) standards were used to assess the severity of OA and the degradation of articular cartilage. The phenotype of cartilage, NF-κB and P21 signaling pathway were measured by Western Blot. The mRNA sequencing was selected to find the differentially expressed genes and potential pathway. Pain of mice was measured by Von Frey hair mechanosensitivity. The senescence level of chondrocyte was SA-β-Gal staining. Results: IGK inhibited catabolism and promoted anabolism after stimulating by IL-1β in vitro. Following destabilization of the medial meniscus (DMM) surgery, administration of IGK significantly reduced OARSI scores and attenuated AGGRECAN and COLLAGEN2 loss, overexpression of MMP3 and articular cartilage deterioration. IGK relieved pain of mice after DMM. Besides, PI3K/AKT/NF-κB, P53, Autophagy, Ferroptosis pathway and reactive oxygen species (ROS), senescence of cartilage were changed after IGK treatment. Conclusion: IGK protects articular cartilage and reduces the progression of OA in a mouse model and shows promise as a potential therapeutic strategy for OA.

Verified
Journal Article
Open access
PDF file
YZYaoyu Zhang
Yaoyu Zhang
MZMeng Zheng
Meng Zheng
TTTingxuan Tang
Tingxuan Tang
JXJun Xiao
Jun Xiao
CLChangyu Liu
Changyu Liu
Osteoarthritis (OA) is characterized by chronic inflammation, and progressive cartilage degradation. Poricoic acid A (PAA), a triterpenoid compound derived from Poria cocos, exhibits anti-inflammatory and anti-fibrotic activities, but its therapeutic potential in OA remains unknown. Here, we investigated the protective effects and mechanisms of PAA in IL-1β-stimulated chondrocytes and a destabilization of a medial meniscus (DMM) mouse model. PAA significantly restored cartilage matrix synthesis, reduced inflammatory catabolism, and alleviated cartilage degeneration in vivo. RNA-seq identified PI3K/AKT signaling as a major pathway regulated by PAA. Mechanistically, PAA stabilized PTEN protein, suppressed PI3K/AKT phosphorylation, and reversed IL-1β-induced cartilage catabolism. PTEN inhibition abolished the beneficial effects of PAA. These findings identify PAA as a promising therapeutic candidate for OA and reveal PTEN-PI3K-AKT as its major regulatory axis.

23 August 2025 in Cellular Signalling
Verified
Journal Article
Open access
KWKang Wei
Kang Wei
YZYi Zou
Yi Zou
HXHuanhuan Xu
Huanhuan Xu
HLHui Liu
Hui Liu
CLChangyu Liu
Changyu Liu
Osteoarthritis (OA), a common degenerative articular disease, is symbolized as joint pain and functional impairment. Chronic inflammation, oxidative stress, and chondrocyte apoptosis are characteristics of the OA pathogenesis. Single-cell RNA sequencing (scRNA-seq) and immunofluorescence of human cartilage demonstrated that the Toll-like receptors 4 (TLR4) expression was increased in OA patients and the function of TLR4 was activated. As specific TLR4 inhibitor, we demonstrated in vitro and in vivo that C34 inhibited the catabolism of chondrocytes and promoted anabolism. C34 restrained pain response, alleviated the lameness, and suppressed expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in mice after destabilized medial meniscus (DMM) surgery. Additionally, C34 restrained angiogenesis associated with OA. Mechanistically, C34 was attributed to suppressing the NF-κB signaling pathways. Our results showed that C34 had anti-OA effects both in vitro and in vivo. These results suggest that targeting TLR4 offered promising therapeutic potential for OA.